Management of infantile hemangiomas during the COVID pandemic
Open Access
- 15 May 2020
- journal article
- research article
- Published by Wiley in Pediatric Dermatology
- Vol. 37 (3), 412-418
- https://doi.org/10.1111/pde.14196
Abstract
The COVID-19 pandemic has caused significant shifts in patient care including a steep decline in ambulatory visits and a marked increase in the use of telemedicine. Infantile hemangiomas (IH) can require urgent evaluation and risk stratification to determine which infants need treatment and which can be managed with continued observation. For those requiring treatment, prompt initiation decreases morbidity and improves long-term outcomes. The Hemangioma Investigator Group has created consensus recommendations for management of IH via telemedicine. FDA/EMA-approved monitoring guidelines, clinical practice guidelines, and relevant, up-to-date publications regarding initiation and monitoring of beta-blocker therapy were used to inform the recommendations. Clinical decision-making guidelines about when telehealth is an appropriate alternative to in-office visits, including medication initiation, dosage changes, and ongoing evaluation, are included. The importance of communication with caregivers in the context of telemedicine is discussed, and online resources for both hemangioma education and propranolol therapy are provided.This publication has 21 references indexed in Scilit:
- Consensus statement for the treatment of infantile haemangiomas with propranololAustralasian Journal of Dermatology, 2017
- PHACE Syndrome: Consensus-Derived Diagnosis and Care RecommendationsThe Journal of Pediatrics, 2016
- Topical Timolol Maleate Treatment of Infantile HemangiomasPEDIATRICS, 2016
- Topical Timolol for Infantile Hemangiomas: Evidence for Efficacy and Degree of Systemic AbsorptionPediatric Dermatology, 2016
- Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce surveyBritish Journal of Dermatology, 2015
- Treatment of infantile haemangiomas: recommendations of a European expert groupEuropean Journal of Pediatrics, 2015
- A Randomized, Controlled Trial of Oral Propranolol in Infantile HemangiomaThe New England Journal of Medicine, 2015
- E-learning enables parents to assess an infantile hemangiomaJournal of the American Academy of Dermatology, 2014
- Propranolol Treatment of Infantile Hemangiomas: Anticipatory Guidance for Parents and CaretakersPediatric Dermatology, 2013
- Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus ConferencePediatrics, 2013